Inogen announces Nabil Shabshab to its Board of Directors as new CEO

– USA, CA – Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Nabil Shabshab to its Board of Directors as President and CEO, effective February 8, 2021, succeeding Scott Wilkinson, who is retiring as President, CEO, and as a director.

“On behalf of the Board of Directors, I would like to congratulate Nabil on this appointment and thank Scott for his significant contributions to Inogen over the last fifteen years. During Scott’s tenure with the company, Inogen became the market leader in portable oxygen concentrators, with best-in-class products and an innovative go to market approach. Nabil is a highly talented and experienced executive who we believe will be critical to Inogen’s plans for growth, as we continue to work towards improving the lives of respiratory therapy patients.” said Board Chairman, Dr. Heath Lukatch.

“I am grateful to have led this outstanding company and to be a part of improving almost a million patients’ lives with our innovative portable oxygen concentrators,” said Scott Wilkinson. “As I previously disclosed, this is the right time for me personally to retire as CEO, and I believe that Inogen will continue to increase patient and physician awareness of our products while also focusing on providing excellent service.”


Nabil Shabshab has served as Worldwide President of Diabetes Care and Digital Health at Becton Dickinson and Company, a leading medical technology company, since August 2017. Before that, since August 2011, Mr. Shabshab served as Becton Dickinson’s Chief Marketing Officer and EVP, Strategic Planning. Before Becton Dickinson, Mr. Shabshab served as EVP, Global Portfolio, Chief Marketing Officer, and Head of RD&E of Diversey, Inc., a cleaning and sanitation solutions company from 2006 to 2010. In his previous roles, Mr. Shabshab served as Principal with The Zyman Group, as VP, Client Solutions and Consulting with Symphony IRI, and in various sales and marketing roles in pharmaceutical and consumer goods companies including Warner-Lambert / Pfizer, the Coca-Cola Company, and Fronterra.

“I am honored for the opportunity to lead Inogen in our mission to increase the freedom and independence for respiratory patients and to make our technologies the standard of care,” said Mr. Shabshab. “I look forward to driving the next phase of Inogen’s success as we continue to seek ways to increase patient access to our technologies, expand the impact we have on patients, drive growth business, and increase value for our stockholders.”

Mr. Shabshab holds an MBA from Northwestern University Kellogg School of Management and a B.S. in Computer Sciences from American Lebanese University.

About Inogen

We are a medical technology company offering innovative respiratory products for use in the homecare setting. We primarily develop, manufacture and market innovative portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.

For more information:

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.